Sensitive ASX Announcement

Neuren completes enrolment in Phase 2 trial in Rett Syndrome

Published: 26/06/14, 08:50am (AEST)2 pages
Neuren Pharmaceuticals Limited
NEU:ASXHealthcare

Recent NEU Announcements

Price Sensitive only